Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$20.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 5 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 39 business days late.
The 20 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Oct 14 | AKTX | Akari Therapeutics Plc | MEXER | 6,186 | $0.0004 | $2 | +18.9% | Open the original filing on SEC.gov |
| Oct 14 | AKTX | Akari Therapeutics Plc | MEXER | 3,866 | $0.0004 | $2 | +13.4% | Open the original filing on SEC.gov |
| Oct 5 | AKTX | Akari Therapeutics Plc | AGRANT | 4,313 | $7.90 | $34.1K | +17.6% | Open the original filing on SEC.gov |
| Oct 1 | ATCH | AtlasClear Holdings, Inc. | AGRANT◆ | 777,332 | — | — | — | Open the original filing on SEC.gov |
| Sep 25 | ATCH | AtlasClear Holdings, Inc. | PBUY↺ | 50,000 | $0.1975 | $9.9K | +5.9% | Open the original filing on SEC.gov |
| Sep 24 | ATCH | AtlasClear Holdings, Inc. | PBUY↺ | 50,000 | $0.2173 | $10.9K | +6.2% | Open the original filing on SEC.gov |
| Aug 18 | AKTX | Akari Therapeutics Plc | AGRANT◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 18 | AKTX | Akari Therapeutics Plc | AGRANT◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 18 | AKTX | Akari Therapeutics Plc | AGRANT | 12,100 | $7.90 | $95.6K | +97.5% | Open the original filing on SEC.gov |
| Jul 14 | ATCH | AtlasClear Holdings, Inc. | AGRANT◆ | 731,030 | — | — | — | Open the original filing on SEC.gov |
| Jul 14 | ATCH | AtlasClear Holdings, Inc. | AGRANT◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 16, 2025 | AKTX | Akari Therapeutics Plc | PDBUY◆ | 154,664 | $0.4041 | $62.5K | — | Open the original filing on SEC.gov |
| Dec 16, 2025 | AKTX | Akari Therapeutics Plc | PDBUY◆ | 154,664 | — | — | — | Open the original filing on SEC.gov |
| Dec 16, 2025 | AKTX | Akari Therapeutics Plc | PDBUY◆ | 247,462 | $0.4041 | $100K | — | Open the original filing on SEC.gov |
| Dec 16, 2025 | AKTX | Akari Therapeutics Plc | PDBUY◆ | 247,462 | — | — | — | Open the original filing on SEC.gov |
| Mar 6, 2025 | AKTX | Akari Therapeutics Plc | AGRANT◆ | 44,642 | $1.12 | $50K | — | Open the original filing on SEC.gov |
| Mar 6, 2025 | AKTX | Akari Therapeutics Plc | AGRANT◆ | 44,642 | $1.12 | $50K | — | Open the original filing on SEC.gov |
| Mar 6, 2025 | AKTX | Akari Therapeutics Plc | AGRANT | 44,642 | $1.12 | $50K | +9.9% | Open the original filing on SEC.gov |